Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-25-034899
Filing Date
2025-04-15
Accepted
2025-04-15 08:00:40
Documents
24
Period of Report
2025-05-29

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm252365-1_pre14a.htm   iXBRL PRE 14A 2663226
6 GRAPHIC lg_adaptimmune-4c.jpg GRAPHIC 15728
7 GRAPHIC bc_capvstsr-4c.jpg GRAPHIC 67678
8 GRAPHIC bc_capvsnetincome-4c.jpg GRAPHIC 65397
9 GRAPHIC lc_performance-4c.jpg GRAPHIC 120214
10 GRAPHIC bc_chiefexecutiveofficer-4c.jpg GRAPHIC 42606
11 GRAPHIC px_adaptimmune25pg01-bw.jpg GRAPHIC 463054
12 GRAPHIC px_adaptimmune25pg02-bw.jpg GRAPHIC 375677
  Complete submission text file 0001104659-25-034899.txt   6696080

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA adap-20241231.xsd EX-101.SCH 7520
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adap-20241231_def.xml EX-101.DEF 2915
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE adap-20241231_lab.xml EX-101.LAB 32544
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adap-20241231_pre.xml EX-101.PRE 6683
27 EXTRACTED XBRL INSTANCE DOCUMENT tm252365-1_pre14a_htm.xml XML 211733
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37368 | Film No.: 25837607
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)